Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Multiple Myeloma"
topic_facet:"Medical Condition: Multiple Myeloma"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Multiple+Myeloma%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Multiple+Myeloma%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (791)
1
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma : Phase 1/2 Investigator Sponsored Study of Selinexor in Combination With High-Dose Melphalan Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
2
A Study of Belantamab Mafodotin Monotherapy in Multiple Myeloma Participants With Normal and Varying Degree of Impaired Renal Function : A Phase I Study to Evaluate the Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) Who Have Normal and Varying Degrees of Impaired Renal Function (DREAMM 12)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
3
An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3) : An Open Label, Randomized Phase 2 Trial of Pomalidomide/Dexamethasone With or Without Elotuzumab in Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Panobinostat (LBH589): Multiple Myeloma - Autologous Hematopoietic Cell Transplantation (HCT) : Evaluation of Panobinostat (LBH589) as Maintenance Therapy in Multiple Myeloma Following Autologous Hematopoietic Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
5
Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care : Assessment of 4 Bone Turnover Markers (C-terminal Telopeptides of Type I Collagene (CTX), Amino-terminal Telopeptide of Type 1 Collagen (NTX), Dickkopf-1 (DKK-1) and Sclerostin (SOST)) in Multiple Myeloma Patients Treated With Intravenous Bisphosphonate
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
6
A Study of CAR-T Cells Targeting GPRC5D in the Treatment of r/r Multiple Myeloma : A Single Arm, Open Label Clinical Study of CAR-T Cells Targeting GPRC5D in the Treatment of Relapsed / Refractory Multiple Myeloma(POLARIS)
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
7
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD : Detect and Profile Multiple Myeloma Measurable Residual Disease (MRD )Prognostics for Monitoring Post-transplant Multiple Myeloma (MM) Patients Receiving Maintenance Therapy.
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
8
MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation : Pilot Study of recMAGE-A3 + AS15 ASCI as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
9
A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma. : A Non-interventional Post Authorisation Registry of Patients Treated With Pomalidomide for Relapsed and Refractory Multiple Myeloma Who Have Received at Least Two Prior Treatment Regimens, Including Both Lenalidomide and Bortezomib, and Have Demonstrated Disease Progression on the Last Therapy
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
10
ctDNA Methylation Sequencing for Myeloma : Circulating Tumor DNA Methylation Sequencing for Multiple Myeloma Minimal Residual Disease Detection and Clonal Evolution Monitoring
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[80]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Multiple Myeloma
Filter aufheben
Thema: Medical Condition: Multiple Myeloma
Medienart
791
Aufsätze
791
E-Artikel
791
E-Ressourcen
Zeitschriftentitel
791
ClinicalTrials.gov
Thema
791
610
Medical Condition: Multiple Myeloma
Multiple Myeloma
751
Neoplasms, Plasma Cell
684
Study Type: Interventional
436
Recruitment Status: Completed
279
Phase: Phase 2
132
Phase: Phase 1
124
Recruitment Status: Terminated
90
Study Type: Observational
88
Phase: Phase 3
86
Phase: Phase 1/Phase 2
64
Recruitment Status: Recruiting
64
Recruitment Status: Unknown status
45
Recruitment Status: Withdrawn
26
Recruitment Status: Active, not recruiting
19
Phase: Phase 1, Phase 2
18
Phase: Early Phase 1
16
Phase: Phase 4
15
Study Type: Expanded Access
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
261
2020-
494
2010-2019
36
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
791
Englisch
Haven't found what you're looking for?
Wird geladen...